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A genome-wide meta-analysis of association studies
of Cloninger’s Temperament Scales
SK Service1, KJH Verweij2,3, J Lahti4, E Congdon1, J Ekelund5,6, M Hintsanen4,7, K Räikkönen4, T Lehtimäki8,9, M Kähönen9,10,
E Widen11, A Taanila12, J Veijola13, AC Heath14, PAF Madden14, GW Montgomery2, C Sabatti15,16, M-R Järvelin17,18,19,20,
A Palotie11,21,22,23, O Raitakari24,25, J Viikari26,27, NG Martin2, JG Eriksson6,28,29,30,31, L Keltikangas-Järvinen4, NR Wray2 and
NB Freimer1,32,33

Temperament has a strongly heritable component, yet multiple independent genome-wide studies have failed to identify
signiﬁcant genetic associations. We have assembled the largest sample to date of persons with genome-wide genotype data,
who have been assessed with Cloninger’s Temperament and Character Inventory. Sum scores for novelty seeking, harm
avoidance, reward dependence and persistence have been measured in over 11 000 persons collected in four different cohorts.
Our study had 480% power to identify genome-wide signiﬁcant loci (Po1.25  108, with correction for testing four scales)
accounting for X0.4% of the phenotypic variance in temperament scales. Using meta-analysis techniques, gene-based tests and
pathway analysis we have tested over 1.2 million single-nucleotide polymorphisms (SNPs) for association to each of the four
temperament dimensions. We did not discover any SNPs, genes, or pathways to be signiﬁcantly related to the four temperament
dimensions, after correcting for multiple testing. Less than 1% of the variability in any temperament dimension appears to be
accounted for by a risk score derived from the SNPs showing strongest association to the temperament dimensions. Elucidation
of genetic loci signiﬁcantly inﬂuencing temperament and personality will require potentially very large samples, and/or a more
reﬁned phenotype. Item response theory methodology may be a way to incorporate data from cohorts assessed with multiple
personality instruments, and might be a method by which a large sample of a more reﬁned phenotype could be acquired.
Translational Psychiatry (2012) 2, e116; doi:10.1038/tp.2012.37; published online 15 May 2012

Introduction
Personality and temperament traits are stable representations
of emotional, motor and attentional reactivity to stimulation, as
manifested by an organized pattern of behavioral responses
across a range of contexts.1 The assessment of personality
and temperament measures in human populations is therefore a major component of efforts to correlate higher
order behaviors with underlying biology. Two common models
for assessing personality include the ﬁve factor model of

personality (FFM)2 and the temperament and character
inventory (TCI).3,4
The big ﬁve factors are openness to experience, conscientiousness, extraversion, agreeableness and neuroticism. Openness to experience is reﬂected in a strong intellectual curiosity
and a preference for novelty and variety. Individuals scoring
high on conscientiousness are characterized as being disciplined, organized and achievement-oriented. The extraversion dimension characterizes the tendency to be active, seek
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out stimulation and the company of others. Agreeableness
evaluates the tendency to be helpful, cooperative and sympathetic towards others. Lastly, emotional stability, impulse
control and anxiety are all components of the Neuroticism
dimension.
The four temperament dimensions of the TCI are harm
avoidance (HA), novelty seeking (NS), reward dependence
(RD) and persistence (P). HA is a tendency to respond
intensively to signals of aversive stimuli, thereby inhibiting
behavior. NS is a tendency to respond with intense excitement
to novel stimuli, or cues for potential rewards or potential
relief of punishment and thereby activating behavior. RD
is a tendency to respond intensely to signals of reward,
especially social rewards, thereby maintaining and continuing
particular behaviors. P is a tendency to persevere in
behaviors that have been associated with reward or relief
from punishment.
Although there is some evidence in support of convergence
between the TCI and FFM, they differ in how the underlying
models were created, with the FFM based on a lexical
analysis of trait adjectives and the TCI based on a theoretical
model that sought to account for individual differences in
personality by integrating neurobiological systems, learning
and social inﬂuences (for a review, see Stallings et al.5). In a
sample of 130 individuals that had been administered both the
TCI and the NEO-PI-R (representing the FFM2), De Fruyt6
used a multiple regression approach to show that 23–51% of
the variance in the TCI scales was explained by the NEO-PI-R
scales, and 29–55% of the variance in the NEO-PI-R scales
were explained by the TCI scales, indicating a substantial
portion of the variance in each of the TCI and NEO-PI-R
unaccounted for by the other.
Personality measures from these models show correlations
to problem behaviors and psychiatric diagnoses,7–12 and may
serve as useful endophenotypes for the study of genetic
components of behavior. An endophenotype is a quantitative,
heritable trait, thought to more directly reﬂect the inﬂuence of
genetic variation.13 Personality dimensions assessed in both
the FFM and TCI demonstrate broad-sense heritability in
excess of 30%,14 and have been the focus of several genomewide association studies (GWAS).
The largest GWAS of personality measures has been
conducted using the NEO-PI-R. de Moor et al.15 analyzed the
FFM dimensions for association to B2.4M single-nucleotide
polymorphisms (SNPs) in a meta-analysis of 17 375 individuals, and while two dimensions (openness to experience and
conscientiousness) were associated at genome-wide signiﬁcance levels to several SNPs, the associations were not
replicated in an independent sample.
Although Cloninger proposed that HA, NS and RD were
inﬂuenced by the serotonergic system, the dopamine system
and the noradrenaline system, respectively,16 genetic evidence to support this assertion has been mixed, and a recent
large meta-analysis of the 5–HTTLPR polymorphism and HA
showed no association.17 Only a single GWAS of the TCI has
been reported to date. Verweij et al.18 tested all four TCI
temperament scales for association with B1.2M SNPs in a
sample of 5117 Australians, employing single-marker analyses, gene-based tests and pathway analyses, and did not
identify any genetic variants to be genome-wide signiﬁcant.
Translational Psychiatry

Although both de Moor and Verweij failed to ﬁnd genomewide association to scales related to personality, there were
key differences between these studies. They used different
instruments to assess personality, and had very different
sample sizes. One cannot rule out that the null results of
de Moor et al.15 were due in part to the instrument used. While
both the TCI and FFM dimensions are clearly heritable, at a
similar magnitude, the locus-speciﬁc heritabilities of dimensions of both instruments are unknown and may differ. That is,
if the proportion of variance in the TCI that is not accounted for
by the FFM has higher locus-speciﬁc heritability than the FFM
dimensions themselves, it is possible that the TCI will have
greater success in genetic mapping. Although the GWAS of
Verweij et al.18 used the TCI, the sample was not powered to
detect genetic variants of small effect size (o1% of the
variance explained). The aim of the current study was to
employ meta-analytic techniques to evaluate the possibility of
small genetic effects on the TCI. By combining four cohorts
totaling over 11 000 persons, this sample has 80% power to
identify association with an SNP responsible for as little as
0.4% of the variance in the temperament scales, at an alpha
level of 1.2  108 (a genome-wide signiﬁcance level of
5  108 corrected for testing four temperament traits).
Additionally, two features of the study design should
minimize the degree of phenotypic and genotypic heterogeneity across the cohorts. First, temperament in all four
cohorts was analyzed using identical items. Second, three
of the four cohorts were derived from Finland, a relatively
genetically homogeneous population.

Materials and methods
Sample descriptions. The Northern Finland Birth Cohort
(NFBC) is a population-based birth cohort comprised of
12 058 individuals born in the northernmost two Finnish
provinces in 1966.19 In 1997, a temperament questionnaire
was given to 5999 individuals who participated at the
age of 31 in a follow-up assessment. Subjects were
asked to complete the questionnaire and return it by
mail; 5105 individuals returned the questionnaire,20 of whom
4508 were genotyped and passed quality control (QC, 55%
female).
The cardiovascular risk in young Finns (YFS) study is a
stratiﬁed random sample of children and adolescents aged
3–18 years from ﬁve university cities and surrounding areas
with medical schools.21,22 Subjects were born in years 1962,
1965, 1968, 1971, 1974 and 1977 and followed up every 3–5
years, beginning in 1980. Temperament data used in these
analyses were collected in 2001; 2105 persons had valid
phenotype data, and of these 1383 were genotyped and
passed QC (54% female). The mean age of participants was
32.5 (±5.1) years.
The Helsinki Birth Cohort Study (HBCS) is a birth cohort
sample of individuals born at Helsinki University Central
Hospital in 1934–44.23–25 Temperament data used in these
analyses were collected in 2004; 1671 persons had valid
phenotype data, and of these 1425 were genotyped and
passed QC (60% female). The mean age of participants was
63.4 (±2.9) years.
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scale used in the YFS was converted to a 0–1 measure by
mapping 1 ¼ 0, 2 ¼ 0.25, 3 ¼ 0.5, 4 ¼ 0.75, and 5 ¼ 1.0. A sum
score across all items in a scale was taken as the ﬁnal
measure. The HBCS sum scores were regressed on age and
sex, and residuals taken as the phenotype. The NFBC sample
was of a uniform age, and the sum score was regressed only
on sex, and residuals taken as the ﬁnal measure. Although the
YFS sample varied in age, age was not signiﬁcantly related to
the sum score for any scale, therefore the score was
regressed only on sex, and residuals taken as the ﬁnal
measure. Data transformations were not employed for NFBC/
YFS analyses, and for HBCS analysis a natural logarithmic
(ln) transform was applied to the HA data.
The means of the raw sum scores are very similar for three
of the four cohorts (Table 1). HBCS, with mean age B30 years
older than the other three cohorts (63 years vs mid-30’s), has
lower average NS and P than the other three cohorts.

The Australian twin registry (QIMR) was initiated in 1978.
Temperament questionnaires were sent to two cohorts
of Australian twins and their families (parents, children,
spouses and siblings), the ﬁrst in 1988 and the second in
1990. A total of 20 464 individuals had valid phenotypic data,
and of these 5117 were genotyped and passed QC
(1727 males and 3390 females, from 2567 independent
families). The mean age of the participants was 36.2 (±12.1)
years. The effective sample size (that is, correcting for nonindependence of family members) was calculated to be 4312.
Verweij et al.18 used this sample in their GWAS of TCI
scales.19
Temperament assessment. Temperament in all samples
was assessed using Cloninger’s TCI.4 The QIMR sample
used a short version (54 dichotomous items26) of the
Tridimensional Personality Questionnaire (TPQ) subset of the
TCI. Although the TPQ originally measured three dimensions, revisions showed that ﬁve items contributing to RD
should be analyzed as a separate P scale, and that one of
the RD items should be assigned to NS. Therefore, the ﬁnal
TPQ measure as obtained in the QIMR sample included 18
HA, 19 NS, 12 RD and 5 P items. For each scale, missing
items were replaced with the mean item score. If individuals
had 425% of the scales’ items missing, their scale score
was treated as missing. Scale scores were transformed by
taking the arcsine of the square root, corrected for the linear
combination of age, age-squared, sex, a sex by age interaction and a sex by age-squared interaction, and standardized
separately for each sex to a mean of 0 and a s.d. of 1.
The NFBC used the TPQ subset of the TCI version 9, with
107 binary items. The YFS used the full TCI version 9 with 240
Likert items. HBCS used the TPQ version 4 with 98 binary
items. NFBC, YFS and HBCS questionnaires were examined
and the subset of questions identical to those administered to
the QIMR sample were identiﬁed and used in all analyses.
Negatively keyed questionnaire items were reverse scored as
necessary. Persons missing 425% of data for a scale were
set to missing for that scale. Persons missing o25% of data
had any missing values imputed by the mean of other persons’
responses (in the same study) to that item. The Likert-like

Genotyping and imputation. Individuals were genotyped
on the following platforms, with the respective genotyping
centers indicated in parentheses: NFBC—Illumina 370duo
Chip (Broad Institute, Cambridge, MA, USA), YFS—Illumina
670K Custom BeadChip, HBCS—Illumina 610K Quad Chip
(Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire,
UK), QIMR samples—Illumina 317K (Finnish Genome
Centre, Helsinki, Finland); Illumina HumanCNV370-Quadv3
(Center for Inherited Disease Research, Baltimore, MD, USA);
Illumina Human610-Quad (DeCode, Reykjavik, Iceland) and
Affymetrix 6.0. (TGen, Phoenix, AZ, USA). Rather than
combining genotype data from different platforms in a joint
analysis of all four cohorts, we used meta-analytic techniques to combine results from association analyses performed separately by cohort (see below).
Sample and SNP-level QC in all Finnish cohorts proceeded
using the same protocols. Individuals were excluded if they
were missing 45% of data, if there was a discrepancy between
reported sex and sex determined from the X chromosome, if
they were sibs or half-sibs of other subjects or if they withdrew
consent. YFS and NFBC subjects were excluded if they had
low IQ (o70). Fewer than 5% of subjects were excluded
during QC. Genotyped SNPs were excluded with call rate

Table 1 Raw sum scores for each scale, by sex and cohort

Sample

Males
N
Mean (s.d.)
HA

NS

NFBC

2007
5.9 (3.9)

2007
8.8 (3.5)

HBCS

567
5.1 (4.1)

574
7.3 (3.6)

YFS

632
6.8 (2.9)

QIMR

1721
6.1 (4.2)

Females
N
Mean (s.d.)
RD

P

HA

NS

RD

P

2009
2.9 (1.2)

2488
6.9 (3.9)

2488
9.4 (3.4)

2483
7.7 (2.3)

2489
2.7 (1.2)

566
6.5 (2.6)

570
1.6 (1.2)

851
6.2 (4.3)

853
7.9 (3.8)

850
7.8 (2.4)

854
1.7 (1.3)

632
8.9 (2.4)

633
6.9 (1.7)

634
2.7 (0.7)

747
6.9 (2.8)

748
9.0 (2.3)

748
7.0 (1.6)

749
2.7 (0.7)

1716
8.5 (3.9)

1721
6.7 (2.7)

1717
3.0 (1.5)

3375
7.9 (4.3)

3371
8.2 (3.7)

3375
8.4 (2.4)

3365
2.9 (1.5)

2005
6.0 (2.5)

Abbreviations: HA, harm avoidance; N, sample size; NS, novelty seeking; P, persistence; RD, reward dependence.
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o95%, P-value from an exact test of Hardy–Weinberg
Equilibrium (HWE) o104 and minor allele frequency o1%.
Imputation to HapMap2 (HM2) was done at the Wellcome
Trust Sanger Institute, separately by cohort, using all samples
that passed QC and all genotyped SNPs that passed QC in an
individual cohort. Imputation was done using Markov Chain
Haplotyper (MaCH),27 and all data were imputed to the
forward/positive strand. The following numbers of SNPs were
successfully imputed with r240.30: NFBC: 2 454 909, YFS:
2 489 350, HBCS: 2 492 667.
Initial QC control in the QIMR sample was applied
separately to different genotype platform data and different
projects. Data were checked for ancestry outliers, Mendelian
errors, HWE failure (excluded if Po106) and minor allele
frequency. After separate QC checks, Illumina and Affymetrix
data were imputed separately by MACH using the data from
the European HM2. SNPs with an imputation quality score (r2)
40.3 were retained, resulting in 2 380 486 Illumina and
2 369 130 Affymetrix SNPs. In addition, QC using individuals
that were imputed on both the Illumina and the Affymetrix
platforms, SNPs were only retained if they had high
concordance rates for the most probable genotype, and had
a minor allele frequency40.01. In total, 1 252 387 SNPs were
available for association analyses. More details on QC
procedures in the QIMR sample can be found in Verweij et al.18
Cohort level analysis. The Finnish HM2 imputed data were
analyzed separately by cohort and followed identical
protocols. A separate analysis was performed for each
scale. Data for HA and RD were also analyzed separately by
sex, as previous work in twins indicated sex differences in the
source of genetic variance for these scales.28 An additive
model was assumed for SNP genotype/dose, and principal
components (from a PCA analysis of the genotype IBS
matrix between persons) that were signiﬁcantly related to the
phenotype were included as covariates (as per the method of
Price et al.29) to guard against possible stratiﬁcation. The ﬁrst
two PCs were always included as covariates, as previous
work showed they correlated strongly with geographic birthplace and ancestry.30 The HM2 imputed dosage data were
analyzed using probABEL.31
For the QIMR sample, the most probable imputed genotype
at each SNP was tested for association with the four TPQ
scales using a family-based association test,32 which takes
family relationships into account (including identical twins).
The additive genetic effect was calculated.
Meta-analysis. Meta-analysis combining results from all
four samples was done using METAL (http://www.sph.umich.
edu/csg/abecasis/metal/) by calculating a Z-statistic that was
a weighted average of sample-level statistics, where the
weights were proportional to the square root of the number of
individuals examined in each sample, and selected so that
the squared weights summed to 1. The weight for QIMR
reﬂected only independent individuals. The direction of effect
in each study was taken into account in calculating the
average. There were 1 252 222 SNPs common to all four
data cohorts and scales. The number of individuals analyzed
varied by phenotype: HA: 11 597, NS: 11 612, RD: 11 590, P:
11 610.
Translational Psychiatry

We also employed the heterogeneity option of METAL. The
METAL heterogeneity analysis requires a second pass of
analysis to decide whether observed effect sizes (or test
statistics) are homogeneous across samples. The resulting
heterogeneity statistic has n–1 degrees of freedom for n
samples.
Gene-based tests. To determine whether any genes harbor
more associated SNPs than expected by chance, we performed a gene-based test for each personality scale (VEGAS,
Versatile Gene-based Association Study33). VEGAS tests for
association on a per-gene basis, by considering the P-value
of all SNPs within genes (including þ /50 kb from the 50 and
30 UTR), accounting for the number of SNPs per gene, and
linkage disequilibrium between the SNPs. As such, the test
identiﬁes genes that show more signals of association than
expected by chance given their length and linkage disequilibrium between the SNPs. The gene-based test was
performed on the meta-analysis association results.
Pathway analysis. Subsequently, all genes from the genebased test with a P-valueo0.01 were included in a pathway
analysis using the Ingenuity Pathway analysis program
(Ingenuity Systems, Redwood City, CA, USA, release IPA 6.0).
By performing these pathway analyses we tried to identify
whether the genes most associated with the personality
scales were more prevalent in any known biological or
canonical pathway than would be expected by chance. The
alpha level was set at 0.0125 (0.05/4 personality scales) and
signiﬁcance of individual pathways was corrected for multiple
testing by the Benjamini–Hochberg procedure as implemented
in Ingenuity. The pathway analysis was performed on the
results from the gene-based test of the meta-analysis results.
Prediction. We used the results from a meta-analysis using
only the three Finnish cohorts to predict the four TCI scales in
the QIMR sample, using the ‘score’ function in PLINK.34 We
restricted this analysis to the same set of SNPs used in the
full meta-analysis, and used only one individual per family.
The ‘risk score’ for individuals in the QIMR sample was
constructed by multiplying the number of copies of the effect
allele at each SNP by the Z-score from the Finnish-only
meta-analysis of a given scale, and summing across SNPs.
The observed TCI score in the QIMR sample was regressed
on this risk score to assess the degree to which variability in
the observed phenotype could be explained by variability in
the risk score. The risk score was calculated using all SNPs,
and also using the top 10, 20, 30, 40 and 50% of SNPs in the
Finnish-only meta-analysis.
Results
Meta-analysis. Genomic control lambda parameters35
estimated from the meta-analysis of 1 252 222 autosomal
SNPs indicated minimal inﬂation of test statistics over the null
value of 1.0; HA: 1.01, NS: 1.04, RD: 1.00, P: 1.02 (Figure 1
QQ plots). No SNPs were signiﬁcant at a genome-wide
threshold of 5  108. The most signiﬁcant ﬁnding was for
rs17608059 on chromosome 17 with scale P, with a P-value
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Figure 1 QQ plots of meta-analysis results for each of the four temperament scales. On the x-axis is the distribution of –log10 P-values expected under the null hypothesis
of no association of SNPs to the phenotype. On the y-axis is the ordered distribution of observed –log10 P-values. Deviation from the 1:1 line in the bulk of the distribution can
suggest inﬂation of test statistics. The 95% conﬁdence bands (dashed lines) are generated assuming the jth order statistic from a uniform (0.1) sample has a beta (j,n–j þ 1)
distribution, and assuming independence. (a) Harm avoidance; (b) novelty seeking; (c) reward dependence; (d) persistence.

of 2.8  107 (Table 2). There were 83 SNPs from 16
independent genomic locations on 12 chromosomes with
Po105 (HA: 9 SNPs, NS: 57 SNPs, RD: 10 SNPs, P: 7
SNPs, Supplemental Table S1). Scales HA and RD were
also analyzed separately by sex; across all four analyses 73
SNPs from 13 independent genomic locations resulted in
Po105 but none were signiﬁcant at a genome-wide level
(Supplemental Table S2). Meta-analysis of the three Finnish
cohorts alone also did not produce any genome-wide
signiﬁcant results (data not shown), nor did meta-analysis
including the heterogeneity option. A priori, both QIMR and
HBCS might be considered to be cohorts with a heterogeneous signal; QIMR due to population differences and
HBCS due to age differences. Among the handful of markers
with METAL heterogeneity Po105 for one or more scales, it
was never true that only the QIMR sample or the HBCS
sample had a test result considered to be heterogeneous
from the other three cohorts.
de Moor et al.15 found two SNPs on 5q14.3 to be genomewide signiﬁcantly associated with openness to experience
(rs1477268 and rs2032794) and one SNP on 18q21.1 to be
genome-wide signiﬁcantly associated with conscientiousness
(rs2576037). Neither association was replicated in an
independent sample. Openness to experience and conscientiousness are not measured in our sample and are only
modestly correlated to our phenotypes (correlations of openness to experience/conscientiousness with NS, HA, P and
RD are 0.27/–0.36, –0.33/–0.24, 0.03/0.46 and 0.32/0.07,

respectively6); however, we still reviewed the association
ﬁndings for these three SNPs in our results. We ﬁnd
rs1477268 and rs2032794 to be associated to NS (P ¼ 0.03).
In de Moor et al.,15 the ‘T’ allele at these markers resulted in a
decrease in openness to experience; we ﬁnd the ‘T’ allele to
result in a decrease in NS. Association of HA, RD and P to
these two SNPs all resulted in P40.30. de Moor et al.15 found
the ‘T’ allele of rs2576037 to result in a decrease in
conscientiousness. In our sample the ‘T’ allele was associated
with a decrease in HA (P ¼ 0.10) and P (P ¼ 0.076).
Association of RD and NS to rs2576047 both resulted in
P40.27.
Gene-based tests and pathway analysis. Approximately
17 200 tests were performed as part of the autosomal genebased analysis. Genomic control parameters indicated
minimal inﬂation of the test statistics over the null value of
1.0; HA: 1.00, NS: 1.04, RD: 0.991, P: 0.963. The percentage
of associations to be signiﬁcant at the 0.05 level range from
4.7% with scale P to 5.5% with scales HA and RD. None of
the scales resulted in gene-based associations that survived
correction for multiple testing (17 261 tests and four scales,
a ¼ 7.2  107). The top ﬁve genes for each scale are
presented in Supplemental Table S3.
We then examined, for each scale, all genes with Po0.01 in
the gene-based test to see whether they were concentrated in
known biological or canonical pathways, using the Ingenuity
Pathway analysis program (Ingenuity Systems, release IPA
Translational Psychiatry
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(0)
APBA2
(0)
LPHN2
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NRXN1
(0)
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(212.5)
FAM92A1
(354.674)
TCERG1L
(220.042)
MSRB3
(0)
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(0)
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(0)
PTPRD
(0)
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T

A

T

T

T

A

T

A

A

T

T

A

T

A
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Gene (kb)

C

G

C

C

G

C

C

G

G

G

C

G

C

G

C

C

A2

5.08E-06
8.63E-06
5.37E-06
2.82E-07

4.562
4.449
4.550
5.135

3.30E-06
3.60E-06

4.651
4.633

1.88E-06

1.87E-06

4.767

4.766

7.41E-06

3.33E-06

4.482

4.649

2.25E-06

1.04E-06

4.730

2.69E-06

4.693

1.59E-06

4.73E-06

5.52E-06

Pval

4.884

4.799

4.576

4.544

Z score

0.718

0.380

0.279

0.504

0.968

0.899

0.749

0.470

0.153

0.580

0.421

0.445

0.192

0.018

0.646

0.154

Freq1

0.14

0.097

0.25

0.036

0.12

4.20E-02

1.36E-01

4.49E-04

1.82E-01

1.38E-01
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2.63E-01
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5.33E-01
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8.59E-01

7.14E-01
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0.10

0.14

0.16

0.20

0.042

0.069

0.35

0.020

0.055
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YFS
(sample size
1379–1383)

0.723

0.390

0.275

0.491

0.965

0.891

0.752

0.479

0.175

0.587

0.401

0.452

0.188

0.020

0.671

0.139

Freq1

0.17

0.11

0.11

0.094

0.20

0.11

0.078

0.20

0.21

0.22

0.27

0.15

0.19

0.92

0.32

0.30
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4.05E-03

4.61E-02

5.41E-02

4.13E-04

4.43E-03

4.90E-03

8.00E-03

5.84E-03

3.68E-02

2.27E-03

4.92E-04

4.51E-02

4.15E-02

1.85E-03

2.55E-04

9.56E-03

NFBC
(sample size
4488–4498)

0.714

0.415

0.290

0.482

0.966

0.912

0.757

0.462

0.167

0.561

0.423

0.433

0.188

0.019

0.656

0.171

Freq1

0.24

0.15

0.081

0.17

0.10

0.12

0.17

0.12

0.37

0.25

0.37

0.32

0.49

0.15

0.022

0.066

Beta

HBCS
(sample size
1409–1425)

1.88E-02

1.01E-01

4.32E-01

2.73E-04

4.61E-01

1.77E-01

3.50E-03

3.80E-01

4.42E-02

7.67E-02

1.10E-02

2.44E-02

5.86E-03

9.45E-02

3.52E-01

2.89E-02

Pval

0.712

0.511

0.286

0.466

0.969

0.891

0.755

0.369

0.210

0.525

0.404

0.378

0.151

0.024

0.713

0.212

Freq1

0.050

0.081

0.079

0.042

0.20

0.091

0.051

0.087

0.091

0.054

0.033

0.099

0.11

0.23

0.075

0.089

Beta

3.02E-02

1.37E-04

6.35E-04

4.84E-02

9.78E-04

7.31E-03

4.01E-02

1.09E-04

5.69E-04

1.14E-02

1.39E-01

1.02E-05

2.33E-04

1.22E-03

1.74E-03

8.11E-04

Pval

QIMR
(effective sample
size ¼ B4312)

Abbreviations: CH, chromosome; HA ¼ harm avoidance, NS ¼ novelty seeking, P ¼ persistence, RD ¼ reward dependence; SNP, single-nucleotide polymorphism. PH is the temperament scale. BP is the physical location
in build 36 basepairs. Gene is the closest gene to the SNP. (kb) is the distance from the SNP. A1 is the reference (effect) allele. Freq1 is the frequency of this allele. Beta is the regression coefﬁcient and indicates the
change in scale for each copy of the A1 allele. HA was ln-transformed for HBCS, and all scales were arcsin square root transformed for QIMR. P val is the P-value associated with either the meta-analytic Z-score or the
study-level Beta. For YFS, NFBC and HBCS, the sample size varied with phenotype, sample size range is indicated.

SNP

PH

Meta-analysis (sample size 11 590–11 612)

Table 2 Meta analysis and individual study-level results for the most signiﬁcant SNPs in each of 16 regions demonstrating association to a temperament phenotype at Po105 in the meta-analysis
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6.0). The number of genes included in this analysis is HA: 193
genes, NS: 198 genes, RD: 225 genes, P: 135 genes. Results
from the pathway analyses were not signiﬁcant after correction for multiple testing, indicating that our top genes were not
over-represented in known biological or canonical pathways
more than one would expect by chance.
Prediction. A risk score calculated from the top 50% of
SNPs in the HA Finnish-only meta-analysis accounted for
0.28% of the variance in HA in the QIMR sample (P ¼ 0.007);
however, this result was not signiﬁcant after correction for
multiple testing (six thresholds and four scales ¼ 24 tests).
The top 10% of SNPs in the RD and P Finnish-only metaanalysis accounted for 0.15% (P ¼ 0.052) and 0.17%
(P ¼ 0.04) of the variance in RD and P in the QIMR sample,
respectively. Using all SNPs in the Finnish-only meta-analysis
of NS accounted for 0.059% (P ¼ 0.22) of the variance in NS
in the QIMR sample. Other SNP thresholds resulted in less of
the variance in the QIMR sample being accounted for by the
risk score (Supplemental Table S4).

Discussion
We report here the results of the largest GWAS conducted to
date for personality assessed using the TCI. The lack of
genome-wide signiﬁcant associations in our meta-analysis of
more than 11 000 subjects, and the lack of replicated associations for personality measured by the NEO-PI-R in an even
larger meta-analysis15 suggest that it will be challenging to
identify such associations using standard approaches for
studying personality traits. Although we ﬁnd modest association of the top ﬁndings of de Moor et al.15 to some of our
phenotypes, the statistical evidence is well below the level
required for replication. Additionally, we ﬁnd no association
evidence to support the suggestion of Cloninger16 that NS, HA
and RD would be inﬂuenced by genes directly affecting the
dopamine, serotoneric or noradrenaline systems, respectively. Two previous studies have identiﬁed genome-wide
signiﬁcant linkage to HA36 and NS.37 None of our top association signals (Po105) for these phenotypes were on the
same chromosomal arms as these linkage ﬁndings.
The true genetic architecture underlying variation in personality is of course unknown, but as with other complex
polygenic phenotypes, causal loci are likely represented by a
mixture of common variants of small effect and rare variants
some of which could have larger effect. Height is a classic
polygenic phenotype; a recent meta-analysis of B180K persons has demonstrated that 10.5% of the phenotypic variation
in height can be explained by 180 associated loci.38 Although
our study is much smaller, it is worth noting that our prediction
analysis accounted for, at most, only 0.28% of the phenotypic
variability in temperament scales.
Our study had 480% power to detect loci responsible for
0.4% of the phenotypic variation in temperament scales, at
genome-wide signiﬁcance levels. Failure of our study to
detect signiﬁcant association to what are clearly heritable
phenotypes suggests that either the true effect sizes of causal
loci are much smaller, and/or that the causal loci are rare and
not well tagged by common variation.

GWAS are designed to identify common polymorphisms
responsible for variation between individuals, and identiﬁcation of common loci with small effects on personality traits
could be possible by assembling very large sample sizes. For
example, GWAS of blood pressure have identiﬁed replicated
associations at genome-wide signiﬁcance but only once
sample sizes in excess of 60 000 individuals were available
for meta-analysis.39 There are substantial obstacles to
amassing a sample of such size for meta-analyses of personality, which do not exist for traits such as blood pressure.
Blood pressure is a relatively direct biological measure, which
is assessed in an objective and standardized way throughout
the world. It is therefore straightforward to combine data
across studies. In sharp contrast, personality trait assessment
relies on self-report instruments, such as the TCI and NEO-PIR, which pose two potential problems. First, while test–retest
correlation for HA, RD and NS range from 0.58 to 0.84, for
measures collected an average of 2 years apart,26 it is
possible that self-report biases and differences in subjective
interpretation of questionnaire items may introduce error in
the assessment of traits. Second, different instruments reﬂect
different models of personality, highlighting philosophical
differences in schools of thought about core components of
personality. It therefore remains unclear to what degree the
phenotypes in individuals assessed via TCI overlap with those
obtained in individuals assessed via NEO-PI-R.
Although combining data from studies using different
personality assessments may enable GWAS of personality
in sample sizes large enough to detect common loci with small
effects on personality, this is a challenging undertaking. A
naı̈ve meta-analysis that would use simple sum scores is
unlikely to be effective, given the modest correlation between
dimensions measured in different instruments (for example,
De Fruyt et al.6 showed the maximum correlation between
dimensions of the TPQ and the FFM to be 0.54). Alternatively,
one might attempt to map in a meta analysis not the sum
scores themselves, but the scores from a principal components analysis that would combine information across scales
within the same instrument, and potentially account for more
of the phenotypic variance. A more sophisticated approach
would be to employ item response theory (IRT40) to estimate
the unmeasured, latent trait thought to be evaluated by
personality assessments. van den Berg et al.41 applied IRT to
the attention problems subscale of the Young Adults Self
Report questionnaire42 assessed in a sample of individuals
from the Netherlands Twin Registry. Heritability of the estimated latent trait was found to be much larger than the
heritability of the traditionally used sum score: 73% vs 40%,
respectively. Using IRT in samples evaluated with different
personality assessments would identify a subset of items in
these different instruments that are related to a common,
unmeasured latent trait. Samples measured with multiple
instruments are needed to identify these items, which are then
extracted from samples evaluated using only one instrument.
Reﬁnement of personality phenotypes in this manner has the
potential to greatly improve power to genetically map these traits.
The results of our meta-analysis, as well as those of
de Moor et al.,15 demonstrate that the null GWAS ﬁndings are
not simply due to the instrument used, and appear to suggest
that successful mapping of loci contributing to personality will
Translational Psychiatry
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require new strategies and methodology. Additionally, nextgeneration sequencing soon will provide a host of data that
may reveal rare variants that, when aggregated in the form
of a ‘burden analysis’,43 account for variability in personality
traits. Understanding the biological processes underlying
personality-related traits would be greatly facilitated by
discovery of any such associated loci, and such loci may also
provide a window for understanding cognitive and behavioral
disorders.
Conﬂict of interest
The authors declare no conﬂict of interest.
Acknowledgements. We thank the study subjects in all four cohorts for
their participation. NFBC: NFBC1966 received ﬁnancial support from the Academy
of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence
in Complex Disease Genetics and SALVE), University Hospital Oulu, Biocenter,
University of Oulu, Finland (75617), the European Commission (EURO-BLCS,
Framework 5 award QLG1-CT-2000-01643), NHLBI grant 5R01HL087679-02
through the STAMPEED program (1RL1MH083268-01), NIH/NIMH
(5R01MH63706:02), ENGAGE project and grant agreement HEALTH-F4-2007201413, the Medical Research Council, UK (G0500539, G0600705, PrevMetSyn/
SALVE), roadmap grants for the Consortium for Neuropsychiatric Phenomics,
UL1-DE019580 and RL1MH083268, for EC; and NIH/NINDS training grant T32
NS048004 for EC. The DNA extractions, sample quality controls, biobank upkeeping and aliquotting was performed in the National Public Health Institute,
Biomedicum Helsinki, Finland and supported ﬁnancially by the Academy of Finland
and Biocentrum Helsinki. We thank Professor Paula Rantakallio (launch of
NFBC1966 and 1986), Ms Outi Tornwall and Ms Minttu Jussila (DNA biobanking).
YFS: YFS has been ﬁnancially supported by the Emil Aaltonen Foundation (MH),
Ella and Georg Ehrnrooth Foundation (MH), and the Academy of Finland: grants
126925, 121584, 124282, 129378 (Salve), 117787 (Gendi) and 41071 (Skidi), the
Social Insurance Institution of Finland, Kuopio, Tampere and Turku University
Hospital Medical Funds (grant 9M048 for TeLeht), Juho Vainio Foundation, Paavo
Nurmi Foundation, Finnish Foundation of Cardiovascular Research and Finnish
Cultural Foundation, Tampere Tuberculosis Foundation and Emil Aaltonen
Foundation (TL). The expert technical assistance in the statistical analyses by
Irina Lisinen and Ville Aalto are gratefully acknowledged. HBCS: We acknowledge
support from grants from the Academy of Finland, the Finnish Diabetes Research
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